Microcap Ledger DocGo Inc. $DCGO
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Services-Health Services
- Headquarters
- New York, NY
- Fiscal year end
- December 31
- Shares outstanding
- 98,928,369 [10-Q 2026-08-17]
What the company doesAI summary of filing
DocGo Inc. provides mobile health services, virtual care management, and medical transportation services across all 50 U.S. states and the United Kingdom. The company operates a vertically integrated platform combining in-person clinicians deployed to patients' homes and workplaces with virtual care providers, supported by a fleet of medical response vehicles. DocGo generates revenue from municipalities, hospitals, health systems, health insurance plans, employers, and government agencies through service delivery contracts; in fiscal 2025, the company derived approximately 38% of revenues from Mobile Health Services and 62% from Transportation Services, with government contracts representing 48% of total revenues, down from 72% in the prior year due to the wind-down of migrant-related programs. The company is revenue-generating and operates three reportable segments: Mobile Health Services, Transportation Services, and Corporate. [10-K 2026-03-16]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $148.98M | −$30.58M | −$13.90M | $25.23M | [10-Q 2026-08-17] |
| FY ended Dec 2025 | $322.20M | −$196.37M | $34.45M | $51.02M | [10-K 2026-03-16] |
| FY ended Dec 2024 | $616.56M | $13.36M | $70.12M | $89.24M | [10-K 2026-03-16] |
- Quarterly cash burn
- −$6.95M
- Cash runway Estimate
- ~10.9 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-05 | 102,050,510 | [10-Q 2024-11-07] |
| 2025-02-25 | 101,982,549 | [10-K 2025-02-27] |
| 2025-05-06 | 99,104,331 | [10-Q 2025-05-08] |
| 2025-08-05 | 97,808,137 | [10-Q 2025-08-07] |
| 2025-11-07 | 97,813,372 | [10-Q 2025-11-10] |
| 2026-03-12 | 98,750,251 | [10-K 2026-03-16] |
| 2026-05-06 | 98,778,413 | [10-Q 2026-05-11] |
| 2026-08-14 | 98,928,369 | [10-Q 2026-08-17] |
Listing status
Current status: 2 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-07-31. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-07-31 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-07-31] |
| 2026-01-30 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-01-30] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-05-12 | Bienstock Lee | other | 15,644 | $0.59 | [4 2026-05-14] |
| 2026-03-30 | Bienstock Lee | other | 18,811 | $0.57 | [4 2026-03-31] |
| 2025-12-15 | Bienstock Lee | other | 214,131 | $0.91 | [4 2025-12-16] |
| 2025-12-15 | Rosenberg Norman | other | 65,774 | $0.91 | [4 2025-12-16] |
| 2025-12-15 | Sugrue Stephen | other | 35,968 | $0.91 | [4 2025-12-16] |
| 2025-12-15 | Tendler Ely D | sell | 16,850 | $0.91 | [4 2025-12-16] |
| 2025-12-12 | Bienstock Lee | grant | 1,113,495 | — | [4 2025-12-16] |
| 2025-12-12 | Rosenberg Norman | grant | 429,405 | — | [4 2025-12-16] |
| 2025-12-12 | Sugrue Stephen | grant | 321,055 | — | [4 2025-12-16] |
| 2025-12-12 | Tendler Ely D | grant | 100,000 | — | [4 2025-12-16] |
| 2025-12-12 | Burdiek Michael J | grant | 150,000 | — | [4 2025-12-16] |
| 2025-12-12 | Leite Etalvina | grant | 150,000 | — | [4 2025-12-16] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-05 | 8-K | Material agreement entered; Material agreement terminated; New financial obligation |
| 2026-08-17 | 10-Q | Quarterly report |
| 2026-08-17 | 8-K | Material agreement entered; Results of operations |
| 2026-08-10 | NT 10-Q | Notice of late quarterly report |
| 2026-07-31 | 8-K | Listing notice or transfer |
| 2026-07-28 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-07-02 | 8-K | Regulation FD disclosure |
| 2026-06-18 | 8-K | Shareholder vote results |
| 2026-05-11 | 10-Q | Quarterly report |
| 2026-05-11 | 8-K | Results of operations |
| 2026-04-22 | DEF 14A | Proxy statement |
| 2026-04-22 | 8-K | Director or officer change |
Alerts for $DCGO
Email me when DocGo Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.